Literature DB >> 20972694

Tumoral calcinosis associated with hypercalcemia in a patient with chronic renal failure.

Ryoko Horikoshi1, Tetsu Akimoto, Daishi Meguro, Osamu Saito, Yasuhiro Ando, Shigeaki Muto, Eiji Kusano.   

Abstract

A 56-year-old male with chronic renal failure was admitted to the hospital because of progressive hip pain, appetite loss, general fatigue, and hypercalcemia. Slight pain had developed in the left hip 3 months before the initiation of hemodialysis, which subsequently developed into hyperalgesia. The patient was suspected to have sarcoidosis based on the elevated serum angiotensin-converting enzyme and lysozyme levels, and the ocular finding characterized by punched out chorioretinal scarring, although this could not be confirmed by histological evaluations. There was an abnormal uptake of gallium in the dependent portion of the tumoral calcinosis, which could have suggested either the presence of granulomatous sarcoid tissue within the calcified mass or active calcification associated with an inflammatory reaction. Elevated serum concentrations of 1,25-dihydroxyvitamin D3, which should be implicated in the development of hypercalcemia, promptly decreased after the administration of steroids. Steroid administration subsequently led to a decrease in the serum calcium and relief of the hip pain. This was a rare case of sarcoidosis associated with symptomatic tumoral calcinosis and hypercalcemia. The diagnostic significance of a gallium scan in this case will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972694     DOI: 10.1007/s10157-010-0362-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  29 in total

Review 1.  Ocular involvement in sarcoidosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages.

Authors:  T Monkawa; T Yoshida; M Hayashi; T Saruta
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

3.  Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a haemodialysis patient: successful treatment using intravenous pamidronate.

Authors:  M K Phanish; G Kallarackal; R Ravanan; T M Lawson; K Baboolal
Journal:  Nephrol Dial Transplant       Date:  2000-10       Impact factor: 5.992

4.  CALCIUM AND PHOSPHORUS METABOLISM IN SARCOIDOSIS.

Authors:  T PUTKONEN; M HANNUKSELA; H HALME
Journal:  Acta Med Scand       Date:  1965-03

5.  1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial.

Authors:  L R Baker; L Abrams; C J Roe; M C Faugere; P Fanti; Y Subayti; H H Malluche
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

6.  Calcium metabolism in sarcoidosis and its clinical implications.

Authors:  M Conron; C Young; H L Beynon
Journal:  Rheumatology (Oxford)       Date:  2000-07       Impact factor: 7.580

Review 7.  Tumoral calcinosis in patients on hemodialysis. Case report and review of the literature.

Authors:  B Pecovnik-Balon; S Kramberger
Journal:  Am J Nephrol       Date:  1997       Impact factor: 3.754

8.  American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

Authors:  Robert A Kyle; Gary C Yee; Mark R Somerfield; Patrick J Flynn; Susan Halabi; Sundar Jagannath; Robert Z Orlowski; David G Roodman; Patricia Twilde; Kenneth Anderson
Journal:  J Clin Oncol       Date:  2007-05-21       Impact factor: 44.544

9.  Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome.

Authors:  Catharina Wenzel; Rupert Bartsch; Dagmar Hussian; Ursula Pluschnig; Gottfried J Locker; Ursula Sevelda; Christoph C Zielinski; Guenther G Steger
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

10.  Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.

Authors:  L Brandi; H Daugaard; E Tvedegaard; T Storm; K Olgaard
Journal:  Nephron       Date:  1989       Impact factor: 2.847

View more
  7 in total

1.  Metastatic calcinosis cutis due to refractory hypercalcaemia responsive to denosumab in a patient with multiple sclerosis.

Authors:  Ahmed Jorge; Robert Szulawski; Fnu Abhishek
Journal:  BMJ Case Rep       Date:  2019-02-25

2.  Sarcoidosis as a cause of unappreciated hypercalcaemia in a patient with end-stage renal disease on peritoneal dialysis.

Authors:  Ami Kwon; Eun Sil Koh; Sungjin Chung; Yong Kyun Kim
Journal:  BMJ Case Rep       Date:  2013-08-01

3.  Bone histomorphometry in a long-term hemodialysis patient with hypoparathyroidism and sarcoidosis.

Authors:  K Sumida; Y Ubara; J Hoshino; N Hayami; T Suwabe; R Hiramatsu; E Hasegawa; M Yamanouchi; N Sawa; T Fujii; K Takaichi
Journal:  Osteoporos Int       Date:  2014-12-13       Impact factor: 4.507

4.  Shoulder pad sign and asymptomatic hypercalcemia in a patient with end-stage kidney disease.

Authors:  Sayoko Izawa; Tetsu Akimoto; Hirokuni Ikeuchi; Eiji Kusano; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2015-03-15

5.  Minimal Change Nephrotic Syndrome Sequentially Complicated by Acute Kidney Injury and Painful Skin Ulcers due to Calciphylaxis.

Authors:  Ryuta Sato; Tetsu Akimoto; Toshimi Imai; Saki Nakagawa; Mari Okada; Atsushi Miki; Shinichi Takeda; Hisashi Yamamoto; Osamu Saito; Shigeaki Muto; Eiji Kusano; Daisuke Nagata
Journal:  Intern Med       Date:  2016-11-15       Impact factor: 1.271

6.  Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.

Authors:  Tetsu Akimoto; Hiromichi Yoshizawa; Yuko Watanabe; Akihiko Numata; Tomoyuki Yamazaki; Eri Takeshima; Kana Iwazu; Takanori Komada; Naoko Otani; Yoshiyuki Morishita; Chiharu Ito; Kazuhiro Shiizaki; Yasuhiro Ando; Shigeaki Muto; Makoto Kuro-o; Eiji Kusano
Journal:  BMC Nephrol       Date:  2012-11-23       Impact factor: 2.388

7.  Sudden onset of parathyroid hormone-independent severe hypercalcemia from reversal of tumoral calcinosis in a dialysis patient.

Authors:  Fareed B Kamar; Bikaramjit Mann; Gregory Kline
Journal:  BMC Nephrol       Date:  2016-09-29       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.